These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30993690)

  • 1. Emerging viruses and current strategies for vaccine intervention.
    Afrough B; Dowall S; Hewson R
    Clin Exp Immunol; 2019 May; 196(2):157-166. PubMed ID: 30993690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory Antibodies Targeting Emerging Viruses: Advancements and Mechanisms.
    Jin J; Simmons G
    Clin Vaccine Immunol; 2016 Jul; 23(7):535-9. PubMed ID: 27226280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel vaccine strategies against emerging viruses.
    García-Sastre A; Mena I
    Curr Opin Virol; 2013 Apr; 3(2):210-6. PubMed ID: 23477832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles-derived vaccines to prevent emerging viral diseases.
    Frantz PN; Teeravechyan S; Tangy F
    Microbes Infect; 2018; 20(9-10):493-500. PubMed ID: 29410084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic.
    Graham BS; Sullivan NJ
    Nat Immunol; 2018 Jan; 19(1):20-28. PubMed ID: 29199281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viruses - from pathogens to vaccine carriers.
    Small JC; Ertl HC
    Curr Opin Virol; 2011 Oct; 1(4):241-5. PubMed ID: 22003377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wanted, dead or alive: new viral vaccines.
    Amanna IJ; Slifka MK
    Antiviral Res; 2009 Nov; 84(2):119-30. PubMed ID: 19733596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies, viruses and vaccines.
    Burton DR
    Nat Rev Immunol; 2002 Sep; 2(9):706-13. PubMed ID: 12209139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A focus on vaccination strategies.
    Woodland DL
    Viral Immunol; 2014 Nov; 27(9):421. PubMed ID: 25361209
    [No Abstract]   [Full Text] [Related]  

  • 10. A focus on humoral immunity to viral infections.
    Woodland DL
    Viral Immunol; 2012 Dec; 25(6):441. PubMed ID: 23216306
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccines and viral antigenic diversity.
    Mumford JA
    Rev Sci Tech; 2007 Apr; 26(1):69-90. PubMed ID: 17633294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine and adjuvant design for emerging viruses: mutations, deletions, segments and signaling.
    Bowick GC; McAuley AJ
    Bioeng Bugs; 2011; 2(3):129-35. PubMed ID: 21637006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting 4-1BB costimulation for enhancing antiviral vaccination.
    Harrison JM; Bertram EM; Ramshaw IA
    Viral Immunol; 2006; 19(4):593-601. PubMed ID: 17201654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single Nucleotide Polymorphism Genotyping Analysis Shows That Vaccination Can Limit the Number and Diversity of Recombinant Progeny of Infectious Laryngotracheitis Viruses from the United States.
    Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Beltrán G; Riblet S; Freitas CO; García M; Devlin JM
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30242009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some unmet challenges in the immunology of viral infections.
    Rouse BT; Lukacher AE
    Discov Med; 2010 Oct; 10(53):363-70. PubMed ID: 21034678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial overview: vaccines against challenging viral pathogens and new vaccine technology.
    Lu S
    Curr Opin Virol; 2014 Jun; 6():viii-ix. PubMed ID: 24831092
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial overview: Preventive and therapeutic vaccines: Vaccination against viral disease - current advances and challenges.
    Rappuoli R; Sutter G
    Curr Opin Virol; 2017 Apr; 23():vi-viii. PubMed ID: 28622999
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
    Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
    Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges.
    Alexander-Miller MA
    J Immunol; 2014 Dec; 193(11):5363-9. PubMed ID: 25411431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.